TCEAL9: A Potential Drug Target for Hypertension (G51186)

Target Name: TCEAL9

NCBI ID: G51186

TCEAL9: A Potential Drug Target for Hypertension

TCEAL9 (WBP5) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of blood pressure and has been shown to play a role in the development and progression of hypertension.

Research has also suggested that TCEAL9 may have potential as a drug target or biomarker for hypertension. One reason for this is that TCEAL9 has been shown to interact with several key signaling pathways that are involved in the regulation of blood pressure.

For example, TCEAL9 has been shown to interact with the renin-angiotensin-aldosterone system (RAAS), a network of enzymes that helps to regulate blood pressure by controlling the levels of angiotensin II, a hormone that causes blood vessels to constrict and raise blood pressure.

In addition to its interaction with the RAAS, TCEAL9 has also been shown to interact with the brain-derived neurotrophic factor (BDNF) pathway, a signaling pathway that is involved in the regulation of brain health and function.

The BDNF pathway is thought to play a key role in the development of hypertension, as it is involved in the regulation of blood pressure and blood vessel diameter. TCEAL9 has been shown to interact with BDNF, which could potentially contribute to its role in the regulation of blood pressure.

Another potential mechanism by which TCEAL9 may contribute to the regulation of blood pressure is its role in the regulation of sodium intake. TCEAL9 is expressed in the kidney and has been shown to play a role in the regulation of sodium intake by the kidney.

Research has suggested that TCEAL9 may be involved in the regulation of sodium intake in a way that contributes to the development of hypertension. This is because people with hypertension are often advised to limit their sodium intake, and TCEAL9 may be involved in the regulation of sodium intake in the body to maintain blood pressure.

In conclusion, TCEAL9 is a protein that has been shown to interact with several key signaling pathways that are involved in the regulation of blood pressure. Its involvement in these pathways makes it a potential drug target or biomarker for hypertension. Further research is needed to fully understand its role in the regulation of blood pressure and to determine its potential as a drug or biomarker.

Protein Name: Transcription Elongation Factor A Like 9

Functions: May be involved in transcriptional regulation

More Common Targets